Supplementary Table_S1: Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system.xlsx
dataset
posted on 2021-06-22, 12:53 authored by Rasmus F Brøndum, Anne Sig Vestergaard, Lars Børty, Charles Vesteghem, Anne Stoffersen Rytter, Marlene M Nielsen, Marianne T. Severinsen, Paw Jensen, Henrik Gregersen, Tarec C. El-Galaly, Karen Dybkær, Lars Holger Ehlers, Martin Bøgsted, Anne Stidsholt Roug|
Supplementary Figure 1. Direct costs of antineoplastic and supportive treatment for progressive multiple myeloma in a tax-based health system
|
